Sign In
Last checked at 
4 Dec 2012 07:00
4 December 2012
Eden Research Plc
("Eden" or "Company")
Appointment of director
Eden Research Plc(AIM: EDEN), the AIM listed agrochemical and encapsulation development company, is pleased to announce that it has appointed Tom Lupton as a non-executive director with immediate effect.
Mr Lupton, aged 56, graduated from Oxford University in 1978 in Agriculture and Forest Sciences. After an executive career in the development and management of agriculture and forestry related enterprises largely in Africa and Asia, Mr Lupton recently was responsible for running a highly visible Farm Project at Sissinghurst.
His previous directorships are as follows:
Camellia PLC | 2002-2006 |
Commonwealth Development Corporation | 1978-2002 |
Tanganyika Wattle Company (Tanzania) | 1996-1996 |
Kilombero Valley Teak Company (Tanzania) | 1996-1996 |
Sable Farming Company Limited (Malawi) | 1993-1996 |
Shiselweni Forestry Company Limited (Swaziland) | 1989-1993 |
There is no further information to be disclosed in accordance with paragraph (g) Schedule Two, Aim Rules for Companies
Sir Ben Gill, Chairman of Eden said, "We are very pleased to welcome Tom to the Board and we welcome his contribution as a non-executive Director. Tom's extensive experience in agriculture and forestry internationally will be invaluable as we continue to target global opportunities in the agrochemical sector for our encapsulation technology."
Enquiries:
Eden Research plc | www.edenresearch.com |
Clive Newitt, Managing Director | Tel: 01993 862 761 |
Alex Abrey, Chief Financial Officer | |
W H Ireland Limited | www.wh-ireland.co.uk |
John Wakefield / Marc Davies | Tel: 0117 945 3471 |
Walbrook PR Ltd | Tel: 020 7933 8780 |
Paul McManus (Media Relations) | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com |
Paul Cornelius (Investor Relations) | Mob: 07827 879 496 or paul.cornelius@walbrookir.com |
Notes:
Eden has developed a terpene-based encapsulation technology which uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.
Terpenes are natural compounds which function as defence mechanisms in many plant groups and are released in response to infection, attack by pests, stress or mechanical injury. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.
Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.
The next-generation encapsulation technology, licensed from University of Massachusetts Medical School ("UMMS") recently, provides significant additional benefits to the original system as it allows release to be controlled by environmental factors rather than relying solely upon the chemistry of the substances used. This means that there is more control over the timing of the release of the active compound being carried allowing for further reduction in chemicals applied whilst ensuring maximum effectiveness.
The UMMS license also significantly expands the potential use of the Eden technology in non-agricultural applications such as health and beauty, cosmetics and animal health.
For more information about Eden, please visit www.edenresearch.com
Follow the stocks
